ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.130
-0.010 (-7.14%)
At close: Dec 5, 2025, 4:00 PM EST
0.133
+0.003 (2.08%)
After-hours: Dec 5, 2025, 7:58 PM EST
ProPhase Labs Employees
ProPhase Labs had 96 employees as of December 31, 2024. The number of employees decreased by 17 or -15.04% compared to the previous year.
Employees
96
Change (1Y)
-17
Growth (1Y)
-15.04%
Revenue / Employee
$52,656
Profits / Employee
-$434,417
Market Cap
6.00M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PRPH News
- 4 days ago - ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript - Seeking Alpha
- 10 days ago - Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1 - GlobeNewsWire
- 16 days ago - ProPhase Labs, Inc. (PRPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. - GlobeNewsWire
- 18 days ago - ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 - GlobeNewsWire
- 19 days ago - ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals - GlobeNewsWire
- 5 weeks ago - ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology - GlobeNewsWire
- 5 weeks ago - ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts - GlobeNewsWire